<DOC>
	<DOC>NCT00273026</DOC>
	<brief_summary>This study will compare patients treated with a marketed medication and those who continue with their usual care to assess the proportion of patients achieving well controlled asthma after 24 weeks.</brief_summary>
	<brief_title>Study In Asthma Control</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<mesh_term>Salmeterol Xinafoate</mesh_term>
	<criteria>documented clinical history of asthma and receiving regular maintenance therapy. Using oral/parenteral or depot corticosteroids within 12 weeks of visit 1. History of heavy smoking or substance abuse. Females who are pregnant or lactating. Required emergency room treatment for their asthma 12 weeks prior to Visit 1. Serious, uncontrolled, systemic disease that may make study participation unsafe or inappropriate in the opinion of the physician. Other medical criteria will be evaluated at the screening visit.</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Asthma Advair</keyword>
</DOC>